Sentence examples for risk of developing serous from inspiring English sources

There are no obvious identifiable risk factors, such as nulliparity, late menopause, hormone replacement therapy, and obesity, linked to the development of serous EIC. 12 According to one review, there is no link between breast and ovarian cancer syndromes and serous EIC. 13 There are no proven strategies or lifestyle modifications that can reduce the overall risk of developing serous EIC.

Women with germ-line BRCA1 or BRCA2 mutation are at increased risk of developing ovarian serous carcinoma while a subset of non-familial ovarian serous carcinomas also demonstrate loss of BRCA1 through either somatic mutations or promoter methylation with transcriptional silencing [2].

Uncovering such differences will improve the ability to intervene in the risk of developing invasive serous PPC.

Transtympanic inoculation of live NTHI developed serous and purulent labyrinthitis after clearance of OM.

About 18% of the patients developed serous retinopathy-like events.

Another developed serous adenocarcinoma of the ovary and fallopian tube (#381, Figure 9), while an additional female developed a tumor of ovarian follicular cells (#383, Figure 9).

Our results showing an increasing risk of invasive serous PPC with older age at last pregnancy suggest differences in cancer development between peritoneal and ovarian carcinomas.

Three SNPs were associated only with reduced risk of invasive serous disease (in PTPRS and BTN3A3), and one SNP associated with increased risk of invasive serous disease (in HEXIM1).

MSL1 gene-level principal components (summarized combinations of genotypes based on two SNPs) were associated with risk of invasive serous disease (p = 0.03).

The results of this study provide evidence for an association between several genes in the DNA repair and response pathways and risk of invasive serous ovarian cancer.

Here, we found that inherited markers in the gene encoding MSL1, part of a complex that modifies the histone H4, may decrease risk of invasive serous ovarian cancer.